These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 17582695

  • 1. Are multiple sclerosis and amyotrophic lateral sclerosis autoimmune disorders of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2008; 70(2):413-8. PubMed ID: 17582695
    [Abstract] [Full Text] [Related]

  • 2. Are vasoactive neuropeptide autoimmune fatigue-related disorders mediated via G protein-coupled receptors?
    Staines D.
    Med Hypotheses; 2005; 65(1):29-31. PubMed ID: 15893112
    [Abstract] [Full Text] [Related]

  • 3. Does dysregulation of key epigenetic and biochemical pathways occur in postulated vasoactive neuropeptide autoimmune disorders?
    Staines DR.
    Med Hypotheses; 2005; 65(6):1154-60. PubMed ID: 16026937
    [Abstract] [Full Text] [Related]

  • 4. Do vasoactive neuropeptide autoimmune disorders explain pyridostigmine's association with Gulf War syndrome?
    Staines D.
    Med Hypotheses; 2005; 65(3):591-4. PubMed ID: 16004938
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Is sudden infant death syndrome (SIDS) an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2004; 62(5):653-7. PubMed ID: 15082084
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Is Gulf War Syndrome an autoimmune disorder of endogenous neuropeptides, exogenous sandfly maxadilan and molecular mimicry?
    Staines DR.
    Med Hypotheses; 2004; 62(5):658-64. PubMed ID: 15082085
    [Abstract] [Full Text] [Related]

  • 9. Does autoimmunity of endogenous vasoactive neuropeptides cause retinopathy in humans?
    Staines DR.
    Med Hypotheses; 2008; 70(1):137-40. PubMed ID: 17560049
    [Abstract] [Full Text] [Related]

  • 10. Postulated vasoactive neuropeptide immunopathology affecting the blood-brain/blood-spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
    Staines DR, Brenu EW, Marshall-Gradisnik S.
    Neuropsychiatr Dis Treat; 2009; 5():81-9. PubMed ID: 19557103
    [Abstract] [Full Text] [Related]

  • 11. Is fibromyalgia an autoimmune disorder of endogenous vasoactive neuropeptides?
    Staines DR.
    Med Hypotheses; 2004; 62(5):665-9. PubMed ID: 15082086
    [Abstract] [Full Text] [Related]

  • 12. Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute-phase response, and nitric oxide production in septic shock.
    Martínez C, Juarranz Y, Abad C, Arranz A, Miguel BG, Rosignoli F, Leceta J, Gomariz RP.
    J Leukoc Biol; 2005 May; 77(5):729-38. PubMed ID: 15661828
    [Abstract] [Full Text] [Related]

  • 13. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
    Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R.
    Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
    [Abstract] [Full Text] [Related]

  • 14. Do vasoactive neuropeptides and heat shock proteins mediate fatigue-related autoimmune disorders?
    Staines DR.
    Med Hypotheses; 2005 Aug; 64(3):539-42. PubMed ID: 15617862
    [Abstract] [Full Text] [Related]

  • 15. Pituitary adenylate cyclase-activating polypeptide induces translocation of its G-protein-coupled receptor into caveolin-enriched membrane microdomains, leading to enhanced cyclic AMP generation and neurite outgrowth in PC12 cells.
    Zhang W, Duan W, Cheung NS, Huang Z, Shao K, Li QT.
    J Neurochem; 2007 Nov; 103(3):1157-67. PubMed ID: 17680996
    [Abstract] [Full Text] [Related]

  • 16. Role of VIP and PACAP in islet function.
    Winzell MS, Ahrén B.
    Peptides; 2007 Sep; 28(9):1805-13. PubMed ID: 17559974
    [Abstract] [Full Text] [Related]

  • 17. Postulated role of vasoactive neuropeptide-related immunopathology of the blood brain barrier and Virchow-Robin spaces in the aetiology of neurological-related conditions.
    Staines DR, Brenu EW, Marshall-Gradisnik S.
    Mediators Inflamm; 2008 Sep; 2008():792428. PubMed ID: 19229345
    [Abstract] [Full Text] [Related]

  • 18. VIP differentially activates beta2 integrins, CR1, and matrix metalloproteinase-9 in human monocytes through cAMP/PKA, EPAC, and PI-3K signaling pathways via VIP receptor type 1 and FPRL1.
    El Zein N, Badran B, Sariban E.
    J Leukoc Biol; 2008 Apr; 83(4):972-81. PubMed ID: 18174366
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic and preventive interventions for postulated vasoactive neuropeptide autoimmune fatigue-related disorders.
    Staines DR.
    Med Hypotheses; 2005 Apr; 65(4):797-803. PubMed ID: 16042995
    [Abstract] [Full Text] [Related]

  • 20. VPAC and PAC receptors: From ligands to function.
    Dickson L, Finlayson K.
    Pharmacol Ther; 2009 Mar; 121(3):294-316. PubMed ID: 19109992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.